FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015452491> ?p ?o ?g. }

• W2015452491 endingPage "567" @default.
• W2015452491 startingPage "557" @default.
• W2015452491 abstract "The safety and immunogenicity of the MRK adenovirus type 5 (Ad5) HIV-1 clade B gag vaccine was assessed in an international Phase I trial. Three-hundred and sixty healthy HIV-uninfected adults were enrolled on five continents. Subjects received placebo or 1 × 109 or 1 × 1010 viral particles (vp) per dose of the MRKAd5 HIV-1 gag vaccine at day 1, week 4, and week 26. Immunogenicity was evaluated using an IFN-γ ELISPOT gag 15-mer assay with positive responses defined as ≥55 SFC/106 PBMCs and ≥4-fold over mock control. The vaccine was well tolerated. The most common adverse events were injection site reactions, headache, pyrexia, diarrhea, fatigue, and myalgia. At week 30, geometric mean ELISPOT responses were 24, 114, and 226 SFC/106 PBMCs in the placebo, 1 × 109 vp/dose, and 1 × 1010 vp/dose groups, respectively. Overall, responses to 1 × 1010 vp were 85% and 68% in subjects with low (≤200) and high (>200) baseline Ad5 titers, respectively. The MRKAd5 HIV-1 gag vaccine was immunogenic in diverse geographic regions. Gag ELISPOT responses were greater in the 1 × 1010 vp/dose groups than in the 1 × 109 vp/dose groups. Data from this first international study indicate that adenovirus-vectored vaccines are well tolerated and may be immunogenic in subjects from regions with high prevalence of preexisting Ad5 immunity." @default.
• W2015452491 created "2016-06-24" @default.
• W2015452491 creator A5009825760 @default.
• W2015452491 creator A5011341715 @default.
• W2015452491 creator A5011671349 @default.
• W2015452491 creator A5014175681 @default.
• W2015452491 creator A5020047598 @default.
• W2015452491 creator A5021479889 @default.
• W2015452491 creator A5028172291 @default.
• W2015452491 creator A5028586840 @default.
• W2015452491 creator A5040809453 @default.
• W2015452491 creator A5045011745 @default.
• W2015452491 creator A5058440042 @default.
• W2015452491 creator A5059368929 @default.
• W2015452491 creator A5063327666 @default.
• W2015452491 creator A5064182369 @default.
• W2015452491 creator A5064789753 @default.
• W2015452491 creator A5064958728 @default.
• W2015452491 creator A5074227104 @default.
• W2015452491 creator A5080796048 @default.
• W2015452491 creator A5088062069 @default.
• W2015452491 date "2011-05-01" @default.
• W2015452491 modified "2023-10-03" @default.
• W2015452491 title "Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults" @default.
• W2015452491 cites W1482036567 @default.
• W2015452491 cites W1808985647 @default.
• W2015452491 cites W1969498684 @default.
• W2015452491 cites W1972315363 @default.
• W2015452491 cites W1974616965 @default.
• W2015452491 cites W1975568458 @default.
• W2015452491 cites W1979754907 @default.
• W2015452491 cites W1985999222 @default.
• W2015452491 cites W1987951457 @default.
• W2015452491 cites W1991893197 @default.
• W2015452491 cites W1993762304 @default.
• W2015452491 cites W2000264869 @default.
• W2015452491 cites W2000591768 @default.
• W2015452491 cites W2004915671 @default.
• W2015452491 cites W2015283768 @default.
• W2015452491 cites W2024097449 @default.
• W2015452491 cites W2026810262 @default.
• W2015452491 cites W2028354331 @default.
• W2015452491 cites W2030129612 @default.
• W2015452491 cites W2030242831 @default.
• W2015452491 cites W2035084589 @default.
• W2015452491 cites W2035555649 @default.
• W2015452491 cites W2048639986 @default.
• W2015452491 cites W2049552324 @default.
• W2015452491 cites W2051108441 @default.
• W2015452491 cites W2051697762 @default.
• W2015452491 cites W2055720257 @default.
• W2015452491 cites W2060744926 @default.
• W2015452491 cites W2065654485 @default.
• W2015452491 cites W2081745197 @default.
• W2015452491 cites W2084052064 @default.
• W2015452491 cites W2089331972 @default.
• W2015452491 cites W2094179245 @default.
• W2015452491 cites W2100990348 @default.
• W2015452491 cites W2102741140 @default.
• W2015452491 cites W2105352387 @default.
• W2015452491 cites W2105809563 @default.
• W2015452491 cites W2105813980 @default.
• W2015452491 cites W2107183650 @default.
• W2015452491 cites W2107419870 @default.
• W2015452491 cites W2108103663 @default.
• W2015452491 cites W2109364135 @default.
• W2015452491 cites W2112111895 @default.
• W2015452491 cites W2112540209 @default.
• W2015452491 cites W2116358235 @default.
• W2015452491 cites W2118570806 @default.
• W2015452491 cites W2122633654 @default.
• W2015452491 cites W2124399955 @default.
• W2015452491 cites W2135151522 @default.
• W2015452491 cites W2135618445 @default.
• W2015452491 cites W2137824026 @default.
• W2015452491 cites W2138671598 @default.
• W2015452491 cites W2143071104 @default.
• W2015452491 cites W2144145615 @default.
• W2015452491 cites W2145525301 @default.
• W2015452491 cites W2146291971 @default.
• W2015452491 cites W2146428988 @default.
• W2015452491 cites W2146634980 @default.
• W2015452491 cites W2148029978 @default.
• W2015452491 cites W2148207513 @default.
• W2015452491 cites W2149148287 @default.
• W2015452491 cites W2151338681 @default.
• W2015452491 cites W2152048324 @default.
• W2015452491 cites W2152640863 @default.
• W2015452491 cites W2153670011 @default.
• W2015452491 cites W2156392662 @default.
• W2015452491 cites W2159044497 @default.
• W2015452491 cites W2162021796 @default.
• W2015452491 cites W2167855043 @default.
• W2015452491 cites W2240372320 @default.
• W2015452491 cites W2317669327 @default.
• W2015452491 cites W4231675953 @default.
• W2015452491 cites W2138981424 @default.
• W2015452491 doi "https://doi.org/10.1089/aid.2010.0151" @default.

• next